Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges

The development of vaccines for microorganisms and bacterial toxins with the potential to be used as biowarfare and bioterrorism agents is an important component of the US biodefense program. DVC is developing two vaccines, one against inhalational exposure to botulinum neurotoxins A1 and B1 and a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Mary Kate, Saviolakis, George A., Welkos, Susan L., House, Robert V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199075/
https://www.ncbi.nlm.nih.gov/pubmed/22028978
http://dx.doi.org/10.1155/2012/731604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199075/
https://www.ncbi.nlm.nih.gov/pubmed/22028978
http://dx.doi.org/10.1155/2012/731604

Ejemplares similares